Global RNA Analysis/Transcriptomics Market

RNA Analysis/Transcriptomics Market: Insights

Transcriptomics is the set of transcripts that occur in every human and is referred to as the analysis of all molecules of the transcript. The transcriptome analysis helps researchers to accurately examine the distribution of genes and the working patterns of each gene in an organism. Some of the major elements expected to encourage growth in the RNA Analysis / Transcriptomics industry are increased advancement in the field of transcriptomics, such as widespread use of RNA sequencing and growing demand for customized medicines. Moreover, the growing incidence of diseases such as diabetes, cancer, and hepatitis B and the growing emphasis on the development of biomarkers are also driving the industry's growth. However, the shortage of trained practitioners and high initial costs are likely to adversely hinder business growth over the expected timeframe.

RNA Analysis/Transcriptomics Market: By Product & Service

This market can be recognized in four product & service-based categories, including consumables/reagents, software, instruments, and services. The category of consumables/reagents is estimated to contribute more to global revenues in the field. The increasing demand in transcriptome studies for high-quality reagents and the frequent use of media and reagents. Increasing R&D initiatives in the pharmaceutical industry and rising government spending in research in the field of life sciences are adding to the consumables sector.

RNA Analysis/Transcriptomics Market: By Application

This market can be supported by four categories, according to the application report: comparative transcriptomics, Toxicogenomics, drug discovery, and clinical diagnostics. It is estimated that drug research will have a higher share in the market than others. It is due to the use of transcriptomics for target recognition and confirmation in drug development, the identification of biomarkers of effectiveness and toxicity from biological fluids, and the study of drug activity and pathways of toxicity. The era of personalized medicine worldwide further stimulates the success of the market.

RNA Analysis/Transcriptomics Market: By End-User

This market can be represented in four divisions, according to the end-user survey: hospitals, CROs, academic research & institutes, and pharmaceutical & biotechnology firms. CROs are balanced by a significant growth pattern in this business sector from 2020 to 2026. CROs provide enterprises and academia with accessible outlets to explore innovative drugs and provide a cost-effective approach to drug growth. Such factors are driving this segment's growth.

RNA Analysis/Transcriptomics Market: By Region

The demand for RNA Analysis/Transcriptomics, depending on the geographical location, is divided into Europe, APAC, North America, CSA, and MEA. The North American region is expected to add to global revenues over the forecast timeframe. This is due to the growth of structure-based drug designs, increasing research in genomics in academic and government will help the North American market flourish. Moreover, high support for life science studies, high spending on biopharmaceutical R&D, and the wider implementation of emerging technology are influencing the region's growth. Furthermore, the Asia-Pacific area is expected to see substantial growth in emerging regions at a quick CAGR. This is due to their low-cost processing advantages and raising understanding of customized therapeutics.

RNA Analysis/Transcriptomics Market: Share & Competitor Analysis

The key players competing in this market are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Promega Corporation, Biomereiux SA, Qiagen N.V., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Merck KGAA, Cd Genomics, Agilent Technologies, Inc., and Illumina, Inc., among others.

In September 2020, Agilent Technologies launched its new product i.e. RNA Reagent Kit, SureSelect XT HS2.

Check the Press Release on Global RNA Analysis/Transcriptomics Market Report